Lilly supports global Dementia Discovery Fund
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
Eli Lilly & Co. (LLY), AstraZeneca (AZN) Extend Immuno-Oncology Collaboration
October 22, 2015 6:21 AM EDTEli Lilly & Co. (NYSE: LLY) and AstraZeneca (NYSE: AZN) announced an extension to their existing immuno-oncology collaboration exploring novel combination therapies for the treatment of patients with solid tumors.
Under the terms of the expanded agreement, Lilly and AstraZeneca will evaluate the safety and efficacy of a range of additional combinations across the companies' complementary portfolios. Lilly will lead the execution of the studies, while both companies will contribute resources. Additional... More
Eli Lilly & Co. (LLY) Will be Key Collaborator in $100M DDF
October 21, 2015 6:34 AM EDTEli Lilly & Co. (NYSE: LLY) announced it will be a key collaborator in the $100 million Dementia Discovery Fund (DDF), which aims to accelerate the discovery and development of new treatments for dementia. This first-ever global dementia research fund recently launched after securing backing from investors including Lilly, the UK Government's Department of Health, Alzheimer's Research UK and a number of other global pharmaceutical companies will invest in research into treatments for the condition.
"Lilly is delighted to be a partner in the Dementia Discovery Fund. Alzheimer's disease is one of... More
